JP2024542840A5 - - Google Patents
Info
- Publication number
- JP2024542840A5 JP2024542840A5 JP2024534140A JP2024534140A JP2024542840A5 JP 2024542840 A5 JP2024542840 A5 JP 2024542840A5 JP 2024534140 A JP2024534140 A JP 2024534140A JP 2024534140 A JP2024534140 A JP 2024534140A JP 2024542840 A5 JP2024542840 A5 JP 2024542840A5
- Authority
- JP
- Japan
- Prior art keywords
- ray powder
- powder diffraction
- solid form
- values
- form according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287212P | 2021-12-08 | 2021-12-08 | |
| US63/287,212 | 2021-12-08 | ||
| PCT/US2022/081060 WO2023107980A1 (en) | 2021-12-08 | 2022-12-07 | Solid state forms of an fgfr inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542840A JP2024542840A (ja) | 2024-11-15 |
| JP2024542840A5 true JP2024542840A5 (cg-RX-API-DMAC7.html) | 2025-12-16 |
Family
ID=86731361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534140A Pending JP2024542840A (ja) | 2021-12-08 | 2022-12-07 | Ｆｇｆｒ阻害剤の固体状形態 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250059170A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4444302A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024542840A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240119095A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118804748A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022407440A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239792A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024001679A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313359A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024006933A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202332432A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023107980A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11345681B1 (en) | 2020-06-05 | 2022-05-31 | Kinnate Biopharma Inc. | Inhibitors of fibroblast growth factor receptor kinases |
| AU2022407439A1 (en) * | 2021-12-08 | 2024-06-27 | Kinnate Biopharma Inc. | Treatment of cancer with an fgfr kinase inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10124003B2 (en) * | 2013-07-18 | 2018-11-13 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for FGFR inhibitor-resistant cancer |
| CN107840842A (zh) * | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
| EP3969442A4 (en) * | 2019-05-17 | 2023-08-02 | Kinnate Biopharma Inc. | FIBROBLAST GROWTH FACTOR RECEPTOR KINASE INHIBITORS |
| US11345681B1 (en) * | 2020-06-05 | 2022-05-31 | Kinnate Biopharma Inc. | Inhibitors of fibroblast growth factor receptor kinases |
-
2022
- 2022-12-07 KR KR1020247022100A patent/KR20240119095A/ko active Pending
- 2022-12-07 CA CA3239792A patent/CA3239792A1/en active Pending
- 2022-12-07 US US18/717,390 patent/US20250059170A1/en active Pending
- 2022-12-07 EP EP22905319.4A patent/EP4444302A4/en active Pending
- 2022-12-07 AU AU2022407440A patent/AU2022407440A1/en active Pending
- 2022-12-07 MX MX2024006933A patent/MX2024006933A/es unknown
- 2022-12-07 IL IL313359A patent/IL313359A/en unknown
- 2022-12-07 TW TW111147070A patent/TW202332432A/zh unknown
- 2022-12-07 CN CN202280091311.6A patent/CN118804748A/zh active Pending
- 2022-12-07 JP JP2024534140A patent/JP2024542840A/ja active Pending
- 2022-12-07 WO PCT/US2022/081060 patent/WO2023107980A1/en not_active Ceased
-
2024
- 2024-06-06 CL CL2024001679A patent/CL2024001679A1/es unknown